A Comparison of Three Methods of Hemoglobin Monitoring in Pediatric Patients Undergoing Major Surgery
Hemoped
Hemoglobin Monitoring During High Bleeding Risk Surgery in Pediatric Patients: Equivalence Study of Hemoglobin Transcutaneous Saturation and Hemocue With Total Serum Hemoglobin
1 other identifier
interventional
50
1 country
1
Brief Summary
Investigators compare the accuracy of the SpHb and hemocue with blood Hb levels
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2015
CompletedFirst Posted
Study publicly available on registry
December 17, 2015
CompletedStudy Start
First participant enrolled
January 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 23, 2016
CompletedAugust 7, 2018
August 1, 2018
11 months
December 8, 2015
August 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparison of hemoglobin measurement using 3 different techniques at the time of transfusion decision
comparison of blood hemoglobin obtained by arterial samples with 2 non invasive methods of measurement using hemocue and SpHb
within the day of surgery
Study Arms (1)
hemoglobine monitoring
OTHER3 different techniques will be used for hemoglobine monitoring : hemocue, pulse co-oxymeter (SpHb) and blood measurement
Interventions
Eligibility Criteria
You may qualify if:
- Paediatric patients scheduled for major orthopaedi or neurosurgical process under general anesthesia Arterial catheter necessary in the anesthetic protocol. BMI\<30 No opposition holders of parental authority and children.
You may not qualify if:
- Hemoglobin disease Pretreatment with erytropoietin or iron
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chru Nancy
Vandœuvre-lès-Nancy, France
Study Officials
- PRINCIPAL INVESTIGATOR
Claude MEISTELMAN, MD
CHRU NANCY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2015
First Posted
December 17, 2015
Study Start
January 5, 2016
Primary Completion
November 23, 2016
Study Completion
November 23, 2016
Last Updated
August 7, 2018
Record last verified: 2018-08